💊 Ozempic is now half price

Good evening. On this week’s menu: retail earnings from Walmart, Target, Home Depot, and Lowe’s will offer a read on the U.S. consumer, while Fed Chair Jerome Powell delivers his final speech Friday with clues on what’s next for interest rates.

⬆︎⬇︎ 1-day change
Market data: today’s market close

WINNERS

⬆︎37.27% GoodRx

Ozempic on sale. The U.S. healthcare savings platform struck a deal with Novo Nordisk to sell Ozempic and Wegovy for $499 a month, the lowest cash price yet for these blockbuster GLP-1 drugs. The move comes just weeks after Novo cut ties with Hims & Hers over its compounded, non-FDA-approved versions of Wegovy, a dispute that has already sparked more than 130 lawsuits. [Read more]

⬆︎25.98% DayForce

Private equity firm Thoma Bravo is reportedly in talks to acquire Dayforce, the HR and payroll software company formerly known as Ceridian. Investors think the moves makes sense, since Dayforce has been trading at a discount despite improving fundamentals against competitors like ADP and Paychex. [Read more]

⬆︎15.97% Applied Digital

The data center operator is building a $3 billion AI campus in North Dakota. Called Polaris Forge 2, the project will cover more than 900 acres, create 200 jobs, and expand on the company’s existing site in the state. Applied Digital is also in talks with a major U.S. customer to anchor the new campus. [Read more]

⬆︎15.03% Newsmax

Lies have price tags. The conservative TV network agreed to pay $67 million to settle a defamation lawsuit with Dominion Voting Systems, which accused the channel of spreading false claims about the 2020 election. A judge had already ruled Newsmax aired defamatory content but left damages up to a jury before the two sides struck a deal. [Read more]

⬆︎14.92% SoHo House

Back to private life. The members-only club operator, which runs more than 40 upscale clubs around the world, agreed to a $2.7 billion buyout from hotel group MCR Hotels. Investors will get $9 a share, a premium of 18% over Friday’s closing price. The move comes after a short-seller report last year that questioned Soho House’s business model. [Read more]

⬆︎12.93% Duolingo

Two fresh analyst upgrades came in for Duolingo: Citi set a $400 price target and KeyBanc went even higher at $460 (the stock was trading around $327 on Friday). Both firms argue the language-learning app’s massive user base and gamified approach give it a strong edge, and that AI is more likely to help than hurt. [Read more]

⬆︎11.35% Sunrun
⬆︎9.69% First Solar

Word got out on Friday, but now it’s official: the Treasury Department has released its new rules for clean energy tax credits. The update is less strict than many feared, dropping the old 5% upfront spending rule for large projects but keeping it in place for smaller ones like rooftop installs. [Read more]

⬆︎3.71% Novo Nordisk

Two big moves in the U.S.: the Danish drugmaker cut the out-of-pocket price of Ozempic and Wegovy to $499 a month for uninsured patients (well below their usual $1,000-plus sticker tags) and secured FDA approval for Wegovy to treat certain liver diseases. [Read more]

⬆︎⬇︎ 1-day change
Market data: today’s market close

IN PARTNERSHIP WITH PACASO

Big investors are buying this “unlisted” stock

When the founder who sold his last company to Zillow for $120M starts a new venture, people notice. That’s why the same VCs behind Uber and eBay also backed Pacaso. They made $110M+ in gross profit to date. They even reserved the Nasdaq ticker PCSO. Now, you can join, too.

Invest for $2.90/Share

_{Paid advertisement for Pacaso’s Regulation A offering. Read the offering circular at invest.pacaso.com. Reserving a ticker symbol is not a guarantee that the company will go public. Listing on the NASDAQ is subject to approvals.}

LOSERS

⬇︎3.66% Intel

Intel may get a new shareholder: the U.S. government. Bloomberg says the U.S. government is weighing turning part of Intel’s $10.9 billion Chips Act funding into stock, giving Uncle Sam about a 10% stake in the chipmaking company. Investors liked the rumor last week, but worries over dilution and political strings are now weighing on the stock. [Read more]

⬇︎3.66% Range
⬇︎4.45% EQT
⬇︎5.69% Antero

Natural gas drillers may have pumped too much gas. Roth Capital cut ratings on all companies above (from Sell to Neutral), warning that U.S. gas supply has surged so much that prices could stay weak until 2026. Production recently jumped back above 109 billion cubic feet per day, pushing storage levels well above the five-year average. [Read more]

⬆︎⬇︎ 1-day change
Market data: today’s market close

EXTRA

FEEDBACK